Liver transplantation for advanced hepatocellular carcinoma.
- Author:
Hae Won LEE
1
;
Kyung Suk SUH
Author Information
- Publication Type:Review
- Keywords: Carcinoma; Hepatocellular; Transplantation, Liver; Selection Criteria; Expanded criteria; Biomarker
- MeSH: Biomarkers, Tumor/analysis; Carcinoma, Hepatocellular/diagnostic imaging/pathology/*therapy; Humans; Liver Neoplasms/diagnostic imaging/pathology/*therapy; Liver Transplantation; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Positron-Emission Tomography
- From:Clinical and Molecular Hepatology 2016;22(3):309-318
- CountryRepublic of Korea
- Language:English
- Abstract: There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded. Based on this idea, various studies have been conducted to further expand the Milan criteria and give more HCC patients a chance of cure. In deceased donor LT (DDLT) setting, expansion of the criteria is relatively tempered because the results of LT for HCC should be comparable to those of patients with non-malignant indications. On the other hand, in living donor LT (LDLT) situation, liver grafts are not public resources. The acceptable target outcomes for LDLT might be much lower than those for DDLT. Patients with biologically favorable tumors might have excellent survivals after LT despite morphological advanced HCCs. Therefore, the significance and utility of biological tumor parameters for selecting suitable LT candidates have been increased to predict HCC recurrence after LT. Although there is no consensus regarding the use of prognostic biomarkers in LT selection criteria for HCC, the combination of conventional morphological parameters and new promising biomarkers could help us refine and expand the LT criteria for HCC in the near future.
